| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | Adalimumab | 4036 | |
| PURCH | PURCH_ATC(L04AB01) | Etanercept | 2810 | |
| PURCH | PURCH_ATC(L04AB06) | Golimumab | 1400 | |
| PURCH | PURCH_ATC(L04AB05) | Certolizumab pegol | 741 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 682 | |
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 664 | |
| PURCH | PURCH_ATC(L04AA24) | Abatacept | 585 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 428 | |
| PURCH | PURCH_ATC(L04AB02) | Infliximab | 297 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 48 |